Mechanisms of reducing joint stiffness by blocking collagen fibrillogenesis in a rabbit model of posttraumatic arthrofibrosis
Related Experiment Video
Updated: Oct 21, 2025
A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit
Published on: November 21, 2023
Andrzej Steplewski1, Jolanta Fertala1, Ryan E Tomlinson1
1Department of Orthopaedic Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
Abstract:
Posttraumatic fibrotic scarring is a significant medical problem that alters the proper functioning of injured tissues. Current methods to reduce posttraumatic fibrosis rely on anti-inflammatory and anti-proliferative agents with broad intracellular targets. As a result, their use is not fully effective and may cause unwanted side effects. Our group previously demonstrated that extracellular collagen fibrillogenesis is a valid and specific target to reduce collagen-rich scar buildup. Our previous studies showed that a rationally designed antibody that binds the C-terminal telopeptide of the α2(I) chain involved in the aggregation of collagen molecules limits fibril assembly in vitro and reduces scar formation in vivo. Here, we have utilized a clinically relevant arthrofibrosis model to study the broad mechanisms of the anti-scarring activity of this antibody. Moreover, we analyzed the effects of targeting collagen fibril formation on the quality of healed joint tissues, including the posterior capsule, patellar tendon, and subchondral bone. Our results show that blocking collagen fibrillogenesis not only reduces collagen content in the scar, but also accelerates the remodeling of healing tissues and changes the collagen fibrils' cross-linking. In total, this study demonstrated that targeting collagen fibrillogenesis to limit arthrofibrosis affects neither the quality of healing of the joint tissues nor disturbs vital tissues and organs.
Insights
This study shows a new antibody effectively reduces fibrotic scarring by targeting collagen formation. This approach improves tissue healing without harming vital organs, offering a safer alternative to current treatments.
Area of Science:
- Biomedical Engineering
- Tissue Engineering
- Regenerative Medicine
Background:
- Posttraumatic fibrotic scarring impairs tissue function, with current treatments having limited efficacy and side effects.
- Existing therapies target broad intracellular pathways, necessitating more specific approaches.
- Extracellular collagen fibrillogenesis presents a specific target for reducing scar tissue accumulation.
Purpose of the Study:
- To investigate the anti-scarring mechanisms of a novel antibody targeting collagen fibrillogenesis in a clinically relevant arthrofibrosis model.
- To evaluate the impact of inhibiting collagen fibril formation on the quality of healed joint tissues.
- To assess the safety and efficacy of targeting collagen fibrillogenesis for scar reduction.
Main Methods:
- Utilized a clinically relevant arthrofibrosis model to assess antibody efficacy.
- Analyzed the effects of blocking collagen fibrillogenesis on scar collagen content and tissue remodeling.
- Examined changes in collagen cross-linking and the quality of healed joint tissues (posterior capsule, patellar tendon, subchondral bone).
Main Results:
- Blocking collagen fibrillogenesis significantly reduced collagen content in scar tissue.
- The antibody treatment accelerated the remodeling of healing joint tissues.
- Targeting collagen fibril formation altered collagen cross-linking without compromising tissue quality or affecting vital organs.
Conclusions:
- Targeting extracellular collagen fibrillogenesis is a specific and effective strategy for reducing posttraumatic fibrotic scarring.
- This approach promotes improved tissue healing and remodeling in arthrofibrosis.
- The developed antibody demonstrates a favorable safety profile, without adverse effects on vital tissues and organs.
More Related Videos
11:03A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model
Published on: October 30, 2019
06:28Anterior Cruciate Ligament Transection and Synovial Fluid Lavage in a Rodent Model to Study Joint Inflammation and Posttraumatic Osteoarthritis
Published on: September 2, 2025
